SCHEMBL15024919

SCHEMBL15024919

Cc1ccc(-c2cc(C3CC4CCC3N4C(=O)OC(C)(C)C)cnc2N)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.37
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
PIK3CA P42336 3/20 0.35
RET P07949 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
SRC P12931 2/20 0.34
HDAC1 Q13547 1/20 0.34
PIK3CD O00329 1/20 0.34
ABL1 P00519 1/20 0.34
EGFR P00533 1/20 0.34
HCK P08631 1/20 0.34
KDR P35968 1/20 0.34
PIK3CB P42338 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34
EPHB4 P54760 1/20 0.34
PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15006726 0.91 CHRNB2 (0.43) CHRM2CHRM1CHRM3PIK3CARET
SCHEMBL10138669 0.90 CHRM2 (0.36) GPR119CHRM2CHRM1CHRM3ADORA2A
SCHEMBL15006886 0.89 PIK3CA (0.44) GPR119PIK3CAPIK3CDMTOR
SCHEMBL15024744 0.89 WNT3A (0.41) GPR119CHRM2CHRM1CHRM3SRC
SCHEMBL10139707 0.88 GPR119 (0.40) GPR119CHRM2CHRM1CHRM3HDAC1
SCHEMBL10139708 0.88 CHEK2 (0.42) GPR119MAP4K4
SCHEMBL15006984 0.88 GPR119 (0.38) GPR119CHRM2CHRM1CHRM3ADORA2A
SCHEMBL10139212 0.87 CHRM2 (0.38) GPR119CHRM2CHRM1CHRM3PIK3CA
SCHEMBL10138721 0.85 UCHL1 (0.36) GPR119CHRM2CHRM1CHRM3
SCHEMBL10138718 0.85 CHRNB2 (0.36) GPR119CHRM2CHRM1CHRM3RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284322-B2 Nicotinic receptor compounds RESEARCH TRIANGLE INSTITUTE (US) 2016-03-15 US disclosed
US-20150152119-A1 NICOTINIC RECEPTOR COMPOUNDS RES TRIANGLE INST (US) 2015-06-04 US disclosed
US-8981102-B2 Nicotinic receptor compounds RESEARCH TRIANGLE INSTITUTE (US) 2015-03-17 US disclosed
US-20130150373-A1 NICOTINIC RECEPTOR COMPOUNDS RESEARCH TRIANGLE INSTITUTE (US) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150373-A1 NICOTINIC RECEPTOR COMPOUNDS CHRNG, CHRNA7, CHRNA2 GPR119 49/4885CHRM2 19/4885CHRM1 23/4885
US-20150152119-A1 NICOTINIC RECEPTOR COMPOUNDS CHRNG, CHRNA7, CHRNA2 GPR119 49/4885CHRM2 19/4885CHRM1 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.